ViiV Healthcare is a global specialty pharmaceutical company dedicated exclusively to the research and development of innovative medicines for individuals living with and at risk of HIV. Established as a joint venture between Pfizer and GlaxoSmithKline in 2009, with Shionogi joining in 2012, ViiV is committed to eradicating HIV/AIDS through a holistic approach that includes education, community support, and improved access to care. With a diverse and inclusive work culture, ViiV Healthcare strives to make a significant impact on the lives of those affected by HIV, offering the largest portfolio of HIV medicines available. The company emphasizes collaboration, innovation, and a mission-driven ethos, ensuring that no person living with HIV is left behind.